Air pollution is a silent and invisible killer more lethal than violence, diseases, and smoking.  More than 95 percent of the global population lives in areas with unhealthy air by WHO standards.  Moreover, long-term exposure to polluted air can increase the probability of succumbing to COVID-19.  

Scientific solutions to contain air pollution are available, but limited progress has been made in implementing them.  Temporally, there has been an uneven success in reducing pollution even in the same locality over time, as exemplified by the exercise of political power to change the color of the sky leading up to the 2008 Beijing Olympics (aka Olympic Blue).  

In this talk, Professor Shen will discuss her new book, The Political Regulation Wave: A Case of How Local Incentives Systematically Shape Air Quality in China (Cambridge University Press, 2022).  Departing from extant works, which focus on air data manipulation or the effect of campaigns, the book asks, what explains the systematic temporal variation in actual and reported air quality after controlling for top-down implementation campaigns?  Making use of new data, approaches, and techniques from across social and environmental sciences, the book shows that local leaders ordered different levels of regulation over time based on what their political superiors desired, leading to the titular “waves” of regulation and pollution.  However, the effectiveness of their regulatory efforts depends on the level of ambiguity in controlling a particular pollutant.  When ambiguity dilutes regulatory effectiveness, having the right incentives and enhanced monitoring is insufficient for successful policy implementation.

You can read and download her book in pdf format here.

Shiran Victoria Shen forged her own path at Stanford University by simultaneously completing a Ph.D. in political science and an MS in civil and environmental engineering in five years after graduating Phi Beta Kappa, Sigma Xi, and with high honors from Swarthmore College. Her research explores the intersections of political science, public policy, environmental sciences, and engineering, with a particular understanding of how local politics influence environmental governance. Her first book, The Political Regulation Wave: A Case of How Local Incentives Systematically Shape Air Quality in China, was published by Cambridge University Press in March 2022.  In dissertation form, it was the recipient of two major association awards, the American Political Science Association’s Harold D. Lasswell Award and the Association for Public Policy Analysis and Management’s Ph.D. Dissertation Award. Earlier versions of its parts received the American Political Science Association’s Paul A. Sabatier Award for the best paper in science, technology & environmental politics and the Southern Political Science Association’s Malcolm Jewell Award for the best overall graduate student paper.

You can learn more about her work at http://svshen.com and follow her on Twitter @SVictoriaShen.

Register: https://bit.ly/3Ncvj7B

AHPP “Aligning incentives” series final webinar: May 12th 6pm PDT, May 13th 9am in Hong Kong and Singapore

How has Myanmar’s health system dealt with the devastation caused by the coup and the pandemic, and what are the current opportunities and challenges for response and recovery? In this panel of two experts, Dr. Thin Zaw will first discuss how Myanmar’s health system and health workforce are endeavoring to respond to the syndemic crisis, a deadly combination of the global pandemic, the military coup, and post-coup civil conflicts. She will also discuss how stakeholders are working together to try to mitigate the crisis, and how a federal health system could be built up to align incentives for effective collaboration among ethnic health organizations. Second, Dr. Tun will provide a grassroots medical humanitarian perspective on what is happening in Myanmar. He will present results of a mixed-methods survey conducted in non-military-controlled areas from October to December 2021, discussing how Myanmar professionals including healthcare workers are spearheading the Civil Disobedience Movement, helping internally displaced people, and trying to address the healthcare needs of populations in conflict areas.

Phyu Phyu Thin Zaw (MBBS, MPP, PhD), who is a Burmese national, is a medical doctor, epidemiologist and health systems researcher currently working as a Lecturer in the School of Public Health in the Li Ka Shing Faculty of Medicine, University of Hong Kong. She is also a member of the Steering Committee of the Science in Exile initiative, which brings together at-risk, displaced and refugee scientists along with like-minded organizations who work together to strengthen systems that support, protect and integrate such affected scientists. Phyu Phyu’s research interests are equity, health and education policies, Southeast Asia health systems and policies, sexual and reproductive health, gender equality, poverty eradication, and human rights issues. Dr. Thin Zaw is also a public health and policy consultant giving technical advice to think tanks and non-governmental organizations.

Nay-Lin Tun (MD, MPP) is a medical doctor by training, and recently earned a Master in Public Policy from the National University of Singapore. He works as a program manager for a local organization that focuses on social cohesion and pluralism among diverse communities. In this role, he manages programs that help vulnerable communities in remote, hard-to-reach, and conflict-affected areas of Myanmar to get access to health services and provide financial assistance to injured civilians who need emergency referrals to private hospitals. Dr. Tun experienced a turning point in his career in 2017 when he went to the conflict-riven northern Rakhine areas. Witnessing people’s suffering and discrimination firsthand compelled him to initiate mobile health clinics and speak out in the media about health care challenges. On a voluntary basis, he is coordinating international donations and grants to field medical teams in conflict-affected areas of the country.

Register: bit.ly/3tymltK

Gender and socioeconomic differences affect a country's ability to support its older adult population. Specifically, the longevity risk associated with females' longer life expectancy entails different needs between genders in old age. In the first project, we aimed to quantify gender differences in the aging experience of OECD countries. Our second project compares differences in projections of disability and chronic diseases among future cohorts of older adults, including disparities by educational attainment. The model projected future chronic diseases and disability trends in Singapore and South Korea from 2020 to 2050. This presentation focuses on gender and socioeconomic differences in aging.

Using administrative data on over 4 million hospital visits, we document striking gender disparities within a government health insurance program that entitles 46 million poor individuals to free hospital care in Rajasthan, India. Females account for only 33% of hospital visits among children and 43% among the elderly. These shares are lower for more expensive types of care, and far lower than sex differences in illness prevalence can explain. Almost two-thirds of non-childbirth spending is on males. We combine these data with patient survey, census, and electoral data to show that 1) the program is unable to fully offset the costs of care-seeking, which results in disparities in hospital utilization because some households are willing to allocate more resources to male than female health; 2) lowering costs does not reduce disparities, because males benefit as much as females do; and 3) long-term exposure to village-level female leaders reduces the gender gap in utilization, but effects are modest and limited to girls and young women. In the presence of gender bias, increasing access to and subsidizing social services may increase levels of female utilization but fail to address gender inequalities without actions that specifically target females.

This event is part of the 2022 Spring webinar series, Negotiating Women's Rights and Gender Equality in Asia, sponsored by the Walter H. Shorenstein Asia-Pacific Research Center.

This event will offer simultaneous translation between Japanese and English. 
当イベントは日本語と英語の同時通訳がついています。

This is a virtual event. Please click here to register and generate a link to the talk. 
The link will be unique to you; please save it and do not share with others.
当イベントはZoomウェビナーで行われます。ウェビナーに参加するためには、こちらのリンクをクリックし、事前登録をして下さい。

Febuary 14, 4-5:30 p.m. California time/ February 15, 9-10:30 a.m. Japan time

This event is part of the 2022 Japan Program Winter webinar series, The Future of Social Tech: U.S.-Japan Partnership in Advancing Technology and Innovation with Social Impact

 

COVID-19 has changed the way we work. While remote work has become the norm, the pandemic has also highlighted the inequity in childcare, elderly care, and household work. Japanese workplaces feel a particularly acute need for adjustment, as lack of digitalization and persistent gender inequality continue to limit productivity gains and diversity in the workforce. Social entrepreneurs in Japan have started offering new technologies that address these problems and transform Japanese work environments, using matching algorithms, innovative apps, and other new technologies. How can these social technologies reshape the workplace? What principles do we need in using these technologies in practice, in order to unlock the keys to untapped human resource potentials and realize a more equitable and inclusive work environment in Japan, the United States, and elsewhere?  Fuhito Kojima, a renowned economist specializing in matching theory, will talk about market design from the perspective of regulation design and economics, and Eiko Nakazawa, an influential entrepreneur, will speak about her experiences founding education and childcare startups in the United States and Japan, moderated by Yasumasa Yamamoto, a leading expert on technology and business in Japan and the United States. 

 

Panelists

Fuhito Kojima is a Professor of Economics at the University of Tokyo and Director of the University of Tokyo Market Design Center. He received a B.A. at University of Tokyo (2003) and PhD at Harvard (2008), both in economics and taught at Yale (2008-2009, as postdoc) and then Stanford (2009-2020, as professor) while spending one year at Columbia in his sabbatical year. His research involves game theory, with a particular focus on “market design,” a field where game-theoretic analysis is applied to study the design of various mechanisms and institutions. His recent works include matching mechanism designs with complex constraints, and he is working on improving medical residency match and daycare seat allocation in Japan based on his academic work. Outside of academia, he serves as an advisor for Keizai Doyu Kai as well as several private companies.

 

Eiko Nakazawa is the Founder and CEO of Dearest, Inc., a VC-Backed startup in the United States that makes high-quality learning, childcare, and parenting support accessible by helping employers subsidize those costs for their working families. She also advises and invests in early-stage startups, and has recently co-founded Ikura, Inc., an education x fintech company in Japan. Prior to founding Dearest, Nakazawa spent 11 years with Sony Corporation, where she led global marketing, turnaround, and new business launch initiatives. Nakazawa earned an M.S. in Management from Stanford Graduate School of Business.

 

 

Moderator

Yasumasa Yamamoto is a Visiting Professor at Kyoto University graduate school of management and has been a specialist in emerging technology such as fintech, blockchain, and deep learning. He was previously industry analyst at Google, senior specialist in quantitative analysis of secularized products, as well as derivatives at Bank of Tokyo Mitsubishi in New York. Yamamoto holds a M.S. from Harvard University and a masters degree from University of Tokyo.

 

This event will offer simultaneous translation between Japanese and English. 
当イベントは日本語と英語の同時通訳がついています。

This is a virtual event. Please click here to register and generate a link to the talk. 
The link will be unique to you; please save it and do not share with others.
当イベントはZoomウェビナーで行われます。ウェビナーに参加するためには、こちらのリンクをクリックし、事前登録をして下さい。

February 7, 5-6:30 p.m. California time/ February 8, 10-11:30 a.m. Japan time

This event is part of the 2022 Japan Program Winter webinar series, The Future of Social Tech: U.S.-Japan Partnership in Advancing Technology and Innovation with Social Impact

Japan’s startup scene has become more exciting in recent years, but in the medical field, the failure to develop COVID-19 vaccines highlighted the shortcomings of Japan’s medical industry. What should Japan do to foster more impactful biotechnology entrepreneurship that would leverage vibrant medical research carried out at Japanese universities? The panel features two speakers who founded and grew their medical ventures in Japan's rapidly maturing startup ecosystem, both with deep connections to university research. 

Tadahisa Kagimoto founded his first company right after finishing his medical degree at Kyushu University, pioneering a pathway of commercializing biotechnology from Japanese university research. His second startup, Healios, founded in 2013 with the goal of becoming a pioneer in regenerative medicine utilizing iPS, was successfully listed on the Tokyo Stock Exchange in 2015 and has been growing since.

Shoko Takahashi was a PhD student in molecular bioscience at the University of Tokyo when she founded her company, Genequest, to offer home DNA testing. The firm was purchased by another biotech startup founded by a University of Tokyo graduate, Euglena, in 2017, and the company has partnered with a variety of pharmaceutical, food and beverage companies, and universities in its research. Their entrepreneurial journeys reveal Japan's changing startup ecosystem that has rapidly matured over the past decade and signal a need for further development in regulatory environments, human resource development, and university-industry collaboration in the biotechnology industry.

 

Panelists

Hardy TS Kagimoto, MD is founder, Chairman and CEO of HEALIOS K.K., a Tokyo-based, clinical-stage world leader in regenerative medicine and cell therapy. 

After founding Healios in 2011, Dr. Kagimoto led the company’s listing on the Tokyo Stock Exchange in 2015 and has built the company to its current scale of more than 140 people across its Japan and US offices. Healios leverages the favorable Japanese regulatory framework for regenerative medicine to efficiently deliver results for patients and its stakeholders. It is currently running two pivotal clinical trials for ischemic stroke and acute respiratory distress syndrome using bone marrow-derived allogeneic multipotent adult progenitor cells. At the same time, Healios is developing best-in-class, next generation pipeline assets in immuno-oncology, ophthalmology, and organ buds utilizing its innovative, proprietary universal donor iPS cell platform.

 

Shoko Takahashi founded the Japanese personal genome company Genequest Inc. in 2013 while a graduate student at the University of Tokyo. Genequest provides a web-based personal genetic service for consumers and collaborates with research institutions in a large-scale genome research project to maximize synergistic effects between research and personal genome services. She is filled with ambition to accelerate genetic research and contribute to human health all over the world. She graduated from the University of Tokyo with a Ph.D. in Molecular Bioscience in 2015, and Kyoto University with a Bachelor of Biochemistry Science in 2010. She has been awarded the Japan Venture Award and received the highest rating by the Japan Ministry of Economy. In 2015, she was commended by the Japan Minister of Education, Culture, Sports, Science and Technology as one of the researchers contributing major innovations to science technologies in Japan.

She received the 2018 Young Global Leaders award from the World Economic Forum and was selected for Newsweek's ‘100 respected Japanese in the world’ list.

 

Moderator

Kenji E. Kushida is a Senior Fellow, Carnegie Endowment for International Peace. He previously was with the Japan Program at the Walter H. Shorenstein Asia-Pacific Research Center as a research scholar.

Kushida’s research and projects focused on the following streams : 1) how politics and regulations shape the development and diffusion of Information Technology such as AI; 2) institutional underpinnings of the Silicon Valley ecosystem, 2) Japan's transforming political economy, 3) Japan's startup ecosystem, 4) the role of foreign multinational firms in Japan, 4) Japan's Fukushima nuclear disaster. He spearheaded the Silicon Valley - New Japan project that brought together large Japanese firms and the Silicon Valley ecosystem.

He has published several books and numerous articles in each of these streams, including “The Politics of Commoditization in Global ICT Industries,” “Japan’s Startup Ecosystem,” "How Politics and Market Dynamics Trapped Innovations in Japan’s Domestic 'Galapagos' Telecommunications Sector," “Cloud Computing: From Scarcity to Abundance,” and others. His latest business book in Japanese is “The Algorithmic Revolution’s Disruption: a Silicon Valley Vantage on IoT, Fintech, Cloud, and AI” (Asahi Shimbun Shuppan 2016).

 

Bhutan time: Friday, February 4th, 2022, 8am to 9am.

Asia Health Policy Program (AHPP) 2021-22 Colloquium series "Aligning Incentives for Better Health and More Resilient Health Systems in Asia”

The Minister of Health of Bhutan, Her Excellency Dasho Dechen Wangmo, will share her insights and experiences from managing the national health system during the COVID-19 crisis, serving as President of the 74th World Health Assembly, and her views on health system strengthening, innovative primary care, chronic disease control, health governance, and the global implications of the pandemic as it unfolds in its third year.

Her Excellency Dasho Dechen Wangmo, the only female Minister in the current cabinet of Bhutan, formally took charge of the Ministry of Health on 7th November 2018. Prior to joining politic in 2018, Her Excellency worked as a public health international consultant with primary focus on health systems, governance, policy and strategic planning for governments and civil societies in many countries (USA, India, Nepal, Bangladesh, PNG, Myanmar, Sri Lanka, Thailand, Senegal). She brings her background working on various global health issues including health system strengthening, health governance, grant implementation, monitoring and evaluation system to the current portfolio.

On 17th December 2020 in recognition of her outstanding service to the Nation, she was conferred the “Red Scarf”, one of highest honors a Bhutanese civilian can receive, by His Majesty the King. Her Excellency is a passionate public health advocate and social worker at heart. Hon’ble Lyonpo was nominated as the President of the 74th World Health Assembly (WHA) by Member States of the WHO’s South East Asia Region in 2020. She will hold the office of the President for a duration of one year and it is an honour bestowed on Bhutan for the first time since it became a member of the WHO in 1982.

In addition to her memberships in professional organizations, she is also a founder of the Bhutan Cancer Society, a CSO working for the well being of cancer patients in Bhutan, and a founding chairperson for Lhaksam, the HIV-positive network in the country. Her Excellency has a Master in Public Health (MPH) from Yale School of Public Health, New Haven, USA, and a Bachelor in Cardiopulmonary Science (magna cum laude) from Northeastern University, Boston, USA.